Paolo Prandoni, MD, PhD; Anthonie W.A. Lensing, MD, PhD; Alberto Cogo, MD, PhD; Stefano Cuppini, MD; Sabina Villalta, MD; Mariarosa Carta, MD; Anna M. Cattelan, MD; Paola Polistena, MD; Enrico Bernardi, MD; Martin H. Prins, MD, PhD
Prandoni P., Lensing A., Cogo A., Cuppini S., Villalta S., Carta M., Cattelan A., Polistena P., Bernardi E., Prins M.; The Long-Term Clinical Course of Acute Deep Venous Thrombosis. Ann Intern Med. 1996;125:1-7. doi: 10.7326/0003-4819-125-1-199607010-00001
Download citation file:
Published: Ann Intern Med. 1996;125(1):1-7.
In patients who have symptomatic deep venous thrombosis, the long-term risk for recurrent venous thromboembolism and the incidence and severity of post-thrombotic sequelae have not been well documented.
To determine the clinical course of patients during the 8 years after their first episode of symptomatic deep venous thrombosis.
Prospective cohort study.
University outpatient thrombosis clinic.
355 consecutive patients with a first episode of symptomatic deep venous thrombosis.
Recurrent venous thromboembolism, the post-thrombotic syndrome, and death. Potential risk factors for these outcomes were also evaluated.
The cumulative incidence of recurrent venous thromboembolism was 17.5% after 2 years of follow-up (95% CI, 13.6% to 22.2%), 24.6% after 5 years (CI, 19.6% to 29.7%), and 30.3% after 8 years (CI, 23.6% to 37.0%). The presence of cancer and of impaired coagulation inhibition increased the risk for recurrent venous thromboembolism (hazard ratios, 1.72 [CI, 1.31 to 2.25] and 1.44 [CI, 1.02 to 2.01], respectively). In contrast, surgery and recent trauma or fracture were associated with a decreased risk for recurrent venous thromboembolism (hazard ratios, 0.36 [CI, 0.21 to 0.62] and 0.51 [CI, 0.32 to 0.87], respectively). The cumulative incidence of the post-thrombotic syndrome was 22.8% after 2 years (CI, 18.0% to 27.5%), 28.0% after 5 years (CI, 22.7% to 33.3%), and 29.1% after 8 years (CI, 23.4% to 34.7%). The development of ipsilateral recurrent deep venous thrombosis was strongly associated with the risk for the post-thrombotic syndrome (hazard ratio, 6.4; CI, 3.1 to 13.3). Survival after 8 years was 70.2% (CI, 64.7% to 75.6%). The presence of cancer increased the risk for death (hazard ratio, 8.1; CI, 3.6 to 18.1).
Patients with symptomatic deep venous thrombosis, especially those without transient risk factors for deep venous thrombosis, have a high risk for recurrent venous thromboembolism that persists for many years. The post-thrombotic syndrome occurs in almost one third of these patients and is strongly related to ipsilateral recurrent deep venous thrombosis. These findings challenge the widely adopted use of short-course anticoagulation therapy in patients with symptomatic deep venous thrombosis.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only